Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000195150 | SCV000247877 | likely benign | not specified | 2015-02-26 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000549951 | SCV000623906 | benign | Chédiak-Higashi syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000195150 | SCV000859127 | likely benign | not specified | 2018-01-22 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002262788 | SCV002543647 | likely benign | Autoinflammatory syndrome | 2021-07-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000549951 | SCV002801883 | likely benign | Chédiak-Higashi syndrome | 2021-08-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003417700 | SCV004126157 | benign | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | LYST: BP4, BS1, BS2 |
Prevention |
RCV003917757 | SCV004732236 | benign | LYST-related disorder | 2019-09-20 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |